← Search all jobs

Fractional Chief Financial Officer

Brio

San Francisco, CA · Fractional, part-time · Posted October 18, 2026

Just laid off? Start here: a plan for the first weeks

Want recruiters in Finance to be able to find you?

Roles at this level, like this one at Brio, are often filled through recruiters.

See every open role at Brio

More in California job market · Financial Services & Banking · Finance jobs

More roles at Brio

Similar jobs

Where San Francisco, CA ranks

Where San Francisco, CA placed in our monthly rankings, month by month. Each month stays online at its own address.

How AI is used in this kind of work

Among personal financial advisors, AI is already used for a large share of the tasks. Measured exposure for personal financial advisors: 35% (high).

Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.

Check how this applies to your own job

Skills this job asks for

Say which you have and which you want to build. We use it to match you to jobs like this one.

  • Audit
  • Forecasting
  • Lean
  • Budgeting
  • GAAP

About the job

BACK TO JOBS Fractional Chief Financial Officer APPLY NOW Fractional Chief Financial Officer Company: Clinical-Stage Biotechnology Company Location: San Francisco, CA Engagement: Fractional Consulting Role The Opportunity Brio Resource Group is partnering with a clinical-stage biotechnology company to identify an experienced Fractional Chief Financial Officer . This executive consulting engagement will provide strategic financial leadership as the company advances its clinical portfolio and prepares for future growth. The ideal candidate combines biotechnology finance expertise with the ability to operate hands-on within a lean organization, advising executive leadership and the Board while strengthening financial planning, controls, reporting, and capital strategy. Key Responsibilities Serve as a strategic financial advisor to the CEO, executive leadership team, and Board of Directors. Lead financial planning, budgeting, forecasting, cash management, and long-range financial modeling. Develop financing strategies aligned with clinical, regulatory, and corporate milestones. Support capital-raising activities, investor engagement, strategic partnerships, and business-development transactions. Provide financial oversight of clinical development programs, vendor commitments, headcount plans, and operating expenses. Strengthen financial reporting, internal controls, accounting processes, and governance. Partner with external accounting, audit, tax, legal, banking, and insurance providers. Prepare financial updates, forecasts, and decision-support materials for leadership and Board meetings. Evaluate licensing, collaboration, acquisition, and other strategic opportunities. Assess organizational needs and help establish a scalable finance infrastructure for continued growth. Qualifications Significant financial leadership experience within biotechnology, pharmaceuticals, or another life sciences organization. Previous CFO, Fractional CFO, or senior finance leadership experience in a clinical-stage biotechnology environment. Demonstrated experience with private and/or public-company financing, investor relations, and Board engagement. Strong understanding of biotechnology development timelines, clinical-program budgeting, cash runway management, and milestone-based planning. Experience supporting fundraising, licensing transactions, strategic partnerships, and financial diligence. Knowledge of GAAP, financial reporting, audit oversight, tax planning, internal controls, and corporate governance. Ability to translate complex financial information into practical strategic guidance. Comfortable operating both strategically and hands-on within a lean, fast-moving organization. CPA, MBA, or other relevant advanced qualification is preferred. Why Consider This Opportunity? This engagement offers the opportunity to work closely with an experienced leadership team, shape financial strategy at a pivotal stage of development, and build the financial foundation required to advance an innovative clinical portfolio and support the company’s next phase of growth.